Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

HER2 status in patients with residual rectal cancer after preoperative chemoradiotherapy: the relationship with molecular results and clinicopathologic features.

Virchows Archiv : an international journal of pathology - 1 Oct 2018

Park Jun Seok, Yoon Ghilsuk, Kim Hye Jin, Park Soo Yeun, Choi Gyu Seog, Kang Min Kyu, Kim Jong Gwang, Jang Jung-Sik, Seo An Na

Abstract excerpt

The specific role of human epidermal growth factor receptor-2 (HER2) status in rectal cancers remains unclear. This study therefore aimed to explore clinicopathologic and molecular characteristics, and prognostic value of HER2-positivity in residual mid- and/or low-rectal cancers after preoperative chemoradiotherapy (CRT). Surgical specimens from 145 patients with residual rectal cancer after preoperative CRT...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Disease-Free Survival
Share to Gene Amplification

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to In Situ Hybridization

Share to Microsatellite Instability

Share to Neoadjuvant Therapy

Share to Neoplasm, Residual

Share to Receptor, ErbB-2

Share to Rectal Neoplasms

Source

Identifiers

PMID: 30056472
DOI: 10.1007/s00428-018-2409-y

Genes

BRAF
KRAS

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

HER2 status in patients with residual rectal cancer after preoperative chemoradiotherapy: the relationship with molecular results and clinicopathologic features.PMID 30056472Read ↗

Clinical significance of fibroblast growth factor receptor 2 expression in patients with residual rectal cancer after preoperative chemoradiotherapy: relationship with KRAS or BRAF mutations and MSI status.Semantic proximity Read ↗

Analysis of Molecular Pretreated Tumor Profiles as Predictive Biomarkers of Therapeutic Response and Survival Outcomes after Neoadjuvant Therapy for Rectal Cancer in Moroccan Population.Semantic proximity Read ↗

Identification of a biomarker profile associated with resistance to neoadjuvant chemoradiation therapy in rectal cancer.Semantic proximity Read ↗

Molecular differentiation between complete and incomplete responders to neoadjuvant therapy in rectal cancerSemantic proximity Read ↗

Pathological Response Has Survival Benefits for Rectal Cancer following Neoadjuvant TherapySemantic proximity Read ↗

Molecular predictors of treatment resistance and recurrence following neoadjuvant therapy in rectal cancer.Semantic proximity Read ↗

Gene expression profile is associated with chemoradiation resistance in rectal cancerSemantic proximity Read ↗

Predictive and Prognostic Molecular Biomarkers for Response to Neoadjuvant Chemoradiation in Rectal Cancer.Semantic proximity Read ↗

Molecular diagnosis of response to neoadjuvant chemoradiation therapy in patients with locally advanced rectal cancer.Semantic proximity Read ↗

Clinical influence of cancer stem cells on residual disease after preoperative chemoradiotherapy for rectal cancer.Semantic proximity Read ↗

Epithelial mesenchymal transition and resistance to neoadjuvant radiotherapy in locally advanced rectal cancerSemantic proximity Read ↗

KRAS mutation status and clinical outcome of preoperative chemoradiation with cetuximab in locally advanced rectal cancer: a pooled analysis of 2 phase II trials.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.